Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Operating margin

Operating margin at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
34.5%+23.0pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-697.7%+635pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-90.5%-41.2pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-33.3%-11.0pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
44.8%+1.6pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-3,020.3%-1,463pp

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×—
P/S5.6×+1.8×

Profitability

See full
Gross margin89.3%+3.5pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

operating income/total revenue=12.4%

Based on trailing twelve months.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's operating margin?
Kiniksa Pharmaceuticals International, plc (KNSA) reported operating margin of 12.4% in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's operating margin changed year-over-year?
Kiniksa Pharmaceuticals International, plc's operating margin increased by 476.4% year-over-year, from -3.3% to 12.4%.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating margin?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's operating margin has grown at a -59.1% compound annual growth rate (CAGR), from -406.4% to 11.4%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.